Body & Brain Yoga Tai Chi to Provide Online Wellness Sessions for AARP Audience
May 08, 2024 05:16 ET
|
Body & Brain
MESA, Ariz., May 08, 2024 (GLOBE NEWSWIRE) -- Body & Brain Yoga Tai Chi, which offers the best in holistic fitness through online and in-studio classes featuring a blend of yoga, tai chi,...
ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator
May 08, 2024 04:00 ET
|
ENA Respiratory
MELBOURNE, Australia, May 08, 2024 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated...
Unveiling the Potential: Beta-Glucan Market Trends and Future Insights
May 08, 2024 04:00 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 08, 2024 (GLOBE NEWSWIRE) -- Beta-glucan is a type of soluble fiber found naturally in foods like oats, barley, mushrooms, and certain yeasts. It is a polysaccharide composed of glucose...
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
May 08, 2024 02:30 ET
|
Abivax
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 PARIS, France, May 8, 2024, 8:30 a.m. CEST –...
ADC Therapeutics veröffentlicht die Finanzergebnisse des ersten Quartals 2024 und gibt aktuelle Informationen zum Geschäftsverlauf bekannt
May 07, 2024 21:42 ET
|
ADC Therapeutics SA
ZYNLONTA® (Loncastuximab-Tesirin-Lpyl) erzielte im 1. Quartal 2024 einen Nettoumsatz von 17,8 Mio. US-Dollar; die Gesamtbetriebskosten sanken um 25% (bereinigte Gesamtbetriebskosten sanken 16 %)1 im...
Denny’s Canada invites guests to enjoy a sweet treat in support of women’s health
May 07, 2024 17:57 ET
|
Denny's Canada
VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- In recognition of Mother’s Day on May 12th, Denny’s Canada is delighted to announce that they have partnered with Women’s Health...
Merus gibt Annahme und vorrangige Prüfung des Lizenzantrags für das Biologikum Zeno zur Behandlung von NRG1+ NSCLC und PDAC durch die US-Zulassungsbehörde FDA bekannt
May 07, 2024 16:12 ET
|
Merus N.V.
UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, May 07, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, das Unternehmen, wir oder unser), ein Unternehmen aus dem Bereich der klinischen...
Merus annonce l’acceptation par la FDA américaine et l’examen prioritaire de la demande de licence de produit biologique relative à Zeno dans le traitement du CPNPC et de l’ACP NRG1+
May 07, 2024 16:12 ET
|
Merus N.V.
UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 07 mai 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : Merus (Merus, la Société, nous ou notre/nos), une société d’oncologie au stade clinique...
Ocular Therapeutix™ Reports First Quarter 2024 Results
May 07, 2024 16:05 ET
|
Ocular Therapeutix, Inc.
Recent Leadership Appointments Put Ocular on Track to Become a Leader in Retinal Care Site Activation and Patient Enrollment for AXPAXLI™ SOL-1 Phase 3 wet AMD Trial Progressing with First Subjects...
Vermont is “SUNucated”
May 07, 2024 15:34 ET
|
American Society for Dermatologic Surgery Association
SCHAUMBURG, Ill., May 07, 2024 (GLOBE NEWSWIRE) -- Vermont children will now be able to possess and utilize sunscreen on school property and at school-sponsored events or activities with the written...